[All Sites]

Contact Molecules for Homologous Proteins

[Summary Bars]
[Full Bars]


Sites by Variants[100 %]


[Back to Search Page]
[Back to HOMCOS]

[SupCon3D]
[help] 		seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100]
[show] [download] [help]
PID QueryLength Homolgous Sequence in PDB UniProt Query TITLE
2931865 365 14 P04439(HLAA_HUMAN) RecName: Full=HLA class I histocompatibility antigen, A alpha chain;AltName: Full=Human leukocyte antigen A; Short=HLA-A;Flags: Precursor;
QUERYSEQ 
MAVMAPRTLLLLLSGALALTQTWAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDQETRNVKAQSQTDRVDLGTLRGYYNQSEAGSHTIQIMYGCDVGSDGRFLRGYRQDAYDGKDYIAL
NEDLRSWTAADMAAQITKRKWEAAHEAEQLRAYLDGTCVEWLRRYLENGKETLQRTDPPKTHMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEL
SSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYTQAASSDSAQGSDVSLTACKV
[BLAST file for PDB] (plain) (bar) (multiple alignment) [BLAST for UniProt: (plain) (bar) (multiple alignment) (PSSM file) ]

Statistics of sites in view of Disease classification

All LB/B (likely benign or benign)
Number of sites 365 70
Buired or ExposedBuried 38.6 (%) [107] 32.7 (%) [17]
Exposed 61.4 (%) [170] 67.3 (%) [35]
Ave relacc 32.5 % 34.7 %
SD relacc 25.99 % 22.24 %
Contact Molhetero 30.4 (%) [111] 41.4 (%) [29]
nucleotide 0.0 (%) [0] 0.0 (%) [0]
compound 0.0 (%) [0] 0.0 (%) [0]
metal 0.0 (%) [0] 0.0 (%) [0]
otherpoly 1.1 (%) [4] 0.0 (%) [0]
homo 0.0 (%) [0] 0.0 (%) [0]
precipitant 14.0 (%) [51] 10.0 (%) [7]
Number of variants 92 92
N_Freq(AAvariant)==0 % 4.3 % [4]
N_Freq(AAvariant)>0 % 95.7 % [88]
Ave Freq(AAvariant) 8.9 %
SD Freq(AAvariant) 8.43 %

Site Table for OMIM:LB/B [92 variants]

70 sites 3,5,10,14,23,33,41,55,59,67,68,80,86,87,89,90,91,94,97,98,100,101,114,119,121,123,129,131,133,138,140,151,166,168,169,173,174,175,176,180,182,185,187,190,191,195,208,210,217,218,231,269,270,277,279,292,300,306,307,312,318,321,322,323,331,334,335,338,345,358
  [n]:site number of query sequence.  [a]:amino acid of query sequence.  [s]:predicted secondary structure.
  [e]:predicted exposed/buried.  [acc]:predicted relative accesssibility(%).  [pdb]:PDB code of homologous structure.
  [contact_mols]:predicted binding molecules  [observed aa]:Observed amino acids among homologous sequences.  [feature table]:UniProt Feature Table
  [variant]:UniProt Human Variant.
n a s e acc pdb contact_mols observed aa feature table variant
3V---- 
VAFTILS
 REGION /note="VL9 epitope" SIGNAL REGION /note="VL9 epitope" DISORDER predicted by DISOPRED SIGNAL V->I:(4.0 %):LB/B -
5A---- 
ALVGMRP
 REGION /note="VL9 epitope" SIGNAL REGION /note="VL9 epitope" DISORDER predicted by DISOPRED SIGNAL A->P:(1.0 %):LB/B -
10L---- 
LFVI
 REGION /note="VL9 epitope" SIGNAL REGION /note="VL9 epitope" DISORDER predicted by DISOPRED SIGNAL L->V:(7.0 %):LB/B -
14S---- 
ASHLIKT
 SIGNAL DISORDER predicted by DISOPRED SIGNAL S->L:(7.0 %):LB/B -
23W---- 
WRQVGPCDHLNAEIKST
 SIGNAL SIGNAL W->R:(11.0 %):LB/B -
33FEb 1.9 8dvg_A hetero B2MG_HUMAN PK3CA_HUMAN NCAP_I46A1 MYPR_HUMAN 
FYLVHIRSEQDT
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" F->S:(6.0 %):LB/B - dbSNP:rs2075684;F->T:(1.0 %):LB/B -;F->Y:(22.0 %):LB/B - dbSNP:rs2075684
41RSe 68.8 8dvg_A hetero B2MG_HUMAN 
RLPSTHEKAIYF
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" R->S:(13.0 %):LB/B - dbSNP:rs1059423
55TEb 17.5 8dvg_A 
QTLEKHR
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" T->S:(0.0 %):LB/B -
59REe 22.1 8dvg_A hetero B2MG_HUMAN precipitant 
RHGTSKPAFMQW
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" R->Q:(1.0 %):LB/B -
67Q e 38.3 8dvg_A 
PRAQGDKSTNEILV
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" Q->R:(18.0 %):LB/B - dbSNP:rs4155911
68RSe 36.4 8dvg_A 
RIKQETFLSAG
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" R->K:(10.0 %):LB/B -
80G e 23.8 8dvg_A 
GASVLREDFIKNPQTY
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" G->E:(4.0 %):LB/B -;G->R:(5.0 %):LB/B - dbSNP:rs1059449
86QHe 55.1 8dvg_A hetero NCAP_I46A1 MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 PK3CA_HUMAN 
RKQNGETHL
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" Q->E:(7.0 %):LB/B -;Q->G:(8.0 %):LB/B -;Q->L:(1.0 %):LB/B -;Q->R:(35.0 %):LB/B -
87EHb 15.6 8dvg_A hetero PK3CA_HUMAN NCAP_I46A1 MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 NCAP_INBAC 
EQVSGLNYDT
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" E->N:(5.0 %):LB/B -;E->Q:(14.0 %):LB/B -
89RHe 77.5 8dvg_A hetero precipitant 
QETRAGFKDMNLW
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" R->G:(7.0 %):LB/B - dbSNP:rs1994744
90NHe 55.2 8dvg_A hetero PK3CA_HUMAN NCAP_I46A1 MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 NCAP_INBAC 
DKNISLATEMRVY
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" N->K:(14.0 %):LB/B - dbSNP:rs1994744
91VHb 4.7 8dvg_A hetero PK3CA_HUMAN NCAP_I46A1 MYPR_HUMAN Q9YV12_9HIV1 NCAP_INBAC 
LAWFIQDGSVYCMT
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" V->M:(1.0 %):LB/B -
94QHb 16.3 8dvg_A hetero PK3CA_HUMAN MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 NCAP_INBAC NCAP_I46A1 
QNWEVKMRHLTDFS
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" Q->H:(4.0 %):LB/B - dbSNP:rs7830686
97THe 43.5 8dvg_A hetero PK3CA_HUMAN NCAP_I46A1 Q9YV12_9HIV1 Q9YYU8_9HIV1 NCAP_INBAC 
TVLIQSMRDAFKNW
 BINDING /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" BINDING /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" T->I:(11.0 %):LB/B - dbSNP:rs1994744
98DHb 0.0 8dvg_A 
FLEYDNS
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" D->H:(0.0 %):LB/B -;D->N:(6.0 %):LB/B -
100VHe 54.7 8dvg_A hetero PK3CA_HUMAN NCAP_I46A1 Q9YV12_9HIV1 Q9YYU8_9HIV1 
VELIADGMRST
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" V->A:(4.0 %):LB/B -;V->E:(14.0 %):LB/B - dbSNP:rs1071742
101DHe 27.8 8dvg_A hetero PK3CA_HUMAN NCAP_I46A1 MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 NCAP_INBAC 
DENTFSAGMV
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" D->N:(13.0 %):LB/B - dbSNP:rs1136688;D->S:(7.0 %):LB/B -
114ASe 67.9 8dvg_A 
DGAKESTFILVNPQRY
 REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" REGION /note="Alpha-1" TOPO_DOM /note="Extracellular" A->D:(18.0 %):LB/B - dbSNP:rs1136692
119IEb 5.3 8dvg_A hetero PK3CA_HUMAN NCAP_I46A1 Q9YYU8_9HIV1 NCAP_INBAC 
LIVFYMR
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" I->L:(46.0 %):LB/B - dbSNP:rs1071743;I->V:(12.0 %):LB/B -
121IEb 3.5 8dvg_A hetero B2MG_HUMAN PK3CA_HUMAN 
VGAWRIFDEMLST
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" I->M:(4.0 %):LB/B - dbSNP:rs1136695;I->R:(8.0 %):LB/B -
123YEb 14.3 8dvg_A hetero PK3CA_HUMAN NCAP_I46A1 MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 NCAP_INBAC 
YALGMFHIRSPEN
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" Y->F:(6.0 %):LB/B - dbSNP:rs1136697
129STe 78.1 8dvg_A 
SEPNAHTRYILF
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" S->P:(14.0 %):LB/B - dbSNP:rs1136700
131G b 17.9 8dvg_A 
GNTEQRSW
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" G->W:(1.0 %):LB/B - dbSNP:rs1136702
133FEe 34.9 8dvg_A 
FLSARTGIYHPVDEKNQ
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" F->L:(14.0 %):LB/B - dbSNP:rs1059488
138REb 12.6 8dvg_A hetero PK3CA_HUMAN NCAP_I46A1 MYPR_HUMAN Q9YYU8_9HIV1 NCAP_INBAC precipitant 
LWEAFRVDKNQGHIMSTYCP
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" R->E:(14.0 %):LB/B -;R->H:(2.0 %):LB/B -;R->Q:(3.0 %):LB/B -
140DEb 10.5 8dvg_A hetero B2MG_HUMAN PK3CA_HUMAN NCAP_I46A1 MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 NCAP_INBAC 
YFVLGEAHDMISKNPRT
 BINDING /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" BINDING /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" D->H:(5.0 %):LB/B -;D->Y:(22.0 %):LB/B -
151N e 27.3 8dvg_A hetero TPSN_HUMAN 
DNQKCERTW
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" N->K:(9.0 %):LB/B - dbSNP:rs1059509
166IHe 35.1 8dvg_A hetero TPSN_HUMAN 
IPVKFWQTALRGNMS
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" I->T:(5.0 %):LB/B - dbSNP:rs1059516
168KHb 17.9 8dvg_A 
KAQNRCETGSDL
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" K->Q:(11.0 %):LB/B -
169RHe 53.4 8dvg_A hetero TPSN_HUMAN 
ERLKQDVAHFMNSTI
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" R->H:(4.0 %):LB/B - dbSNP:rs1059520
173AHe 69.6 8dvg_A hetero precipitant 
SAKYNQLTDPVEGRCH
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" A->T:(5.0 %):LB/B - dbSNP:rs1059526
174AHe 53.6 8dvg_A hetero PK3CA_HUMAN Q9YV12_9HIV1 precipitant 
QALDKEINVYHRST
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" A->V:(5.0 %):LB/B -
175HTe 54.5 8dvg_A hetero PDIA3_HUMAN precipitant 
KPGHRSDYNMAEFILQCV
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" H->R:(8.0 %):LB/B -
176EHe 41.2 8dvg_A hetero PK3CA_HUMAN NCAP_I46A1 MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 NCAP_INBAC precipitant 
EDIKRYGTAQFVLW
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" E->A:(4.0 %):LB/B -;E->R:(7.0 %):LB/B -;E->V:(2.0 %):LB/B - dbSNP:rs9256983;E->W:(1.0 %):LB/B -
180LHb 14.0 8dvg_A hetero PK3CA_HUMAN NCAP_I46A1 MYPR_HUMAN Q9YV12_9HIV1 NCAP_INBAC 
VKTALRSIEFHNQDMWY
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" L->Q:(4.0 %):LB/B -;L->R:(8.0 %):LB/B -;L->W:(1.0 %):LB/B - dbSNP:rs9260156
182AHe 51.8 8dvg_A hetero 
ANTHKQSDIRVWEGLY
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" A->V:(2.0 %):LB/B -
185DTe 35.2 8dvg_A 
DESNLKHQRTGY
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" D->E:(25.0 %):LB/B - dbSNP:rs1059542
187THe 46.1 8dvg_A hetero MYPR_HUMAN Q9YYU8_9HIV1 NCAP_I46A1 
TVDEYINSLAGKMP
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" T->E:(10.0 %):LB/B -;T->R:(0.0 %):LB/B -
190EHe 37.2 8dvg_A 
EQRHAGLSDMTFIKNPVY
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" E->D:(2.0 %):LB/B - dbSNP:rs8795778
191WHe 25.5 8dvg_A hetero PK3CA_HUMAN NCAP_I46A1 MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 NCAP_INBAC 
WFYQLNRSIMEKTADGHPVC
 REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" W->G:(2.0 %):LB/B - dbSNP:rs3098019
195YHb 2.2 8dvg_A hetero PK3CA_HUMAN NCAP_I46A1 MYPR_HUMAN Q9YV12_9HIV1 Q9YYU8_9HIV1 NCAP_INBAC 
YHFLNVEIG
 BINDING /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" BINDING /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" REGION /note="Alpha-2" TOPO_DOM /note="Extracellular" Y->H:(12.0 %):LB/B -
208P e 31.8 8dvg_A 
PEKQARSCFHT
 REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DISORDER predicted by DISOPRED REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" P->A:(5.0 %):LB/B -
210KEe 65.1 8dvg_A 
KVESTLMQNRD
 DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DISORDER predicted by DISOPRED DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" K->R:(2.0 %):LB/B -
217PEe 69.8 8dvg_A 
PENSQVAKRW
 DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" P->A:(2.0 %):LB/B -
218ISe 52.6 8dvg_A 
VALSTIYGREPFDNQ
 DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" I->V:(18.0 %):LB/B -
231GEe 33.3 8dvg_A 
GDNSKQR
 DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" G->S:(7.0 %):LB/B -
269AEb 0.0 8dvg_A 
VASHCLMNYEI
 DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" A->V:(34.0 %):LB/B -
270AEb 3.6 8dvg_A 
SYTAMHLVERFKI
 DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" A->S:(20.0 %):LB/B -
277E e 33.2 8dvg_A 
EDSQNRKPATVLYGH
 DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" E->K:(4.0 %):LB/B -;E->Q:(9.0 %):LB/B -
279QGe 50.0 8dvg_A 
DQAEHPSTVNK
 DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" Q->K:(1.0 %):LB/B -
292KSe 61.3 8dvg_A 
QEKSDMARTGHNV
 DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" DOMAIN /note="Ig-like C1-type" REGION /note="Alpha-3" TOPO_DOM /note="Extracellular" K->E:(25.0 %):LB/B -
300L e 36.0 8dvg_A 
APLSFKEHQCGNTDIRV
 REGION /note="Connecting peptide" TOPO_DOM /note="Extracellular" REGION /note="Connecting peptide" TOPO_DOM /note="Extracellular" L->P:(21.0 %):LB/B -
306I---- 
ILVMSRWEQKFTADGNP
 REGION /note="Connecting peptide" TOPO_DOM /note="Extracellular" REGION /note="Connecting peptide" TOPO_DOM /note="Extracellular" I->V:(12.0 %):LB/B -
307P---- 
PSLGIATVKMNQYDEFR
 REGION /note="Connecting peptide" TOPO_DOM /note="Extracellular" REGION /note="Connecting peptide" TOPO_DOM /note="Extracellular" P->H:(0.0 %):LB/B -
312I---- 
VISALFGMT
 TRANSMEM /note="Helical" TRANSMEM /note="Helical" I->L:(4.0 %):LB/B -
318L---- 
LVFIACGYDEKNPQRST
 TRANSMEM /note="Helical" TRANSMEM /note="Helical" L->F:(7.0 %):LB/B -
321V---- 
VILAGFMT
 TRANSMEM /note="Helical" TRANSMEM /note="Helical" V->M:(1.0 %):LB/B -
322I---- 
IVLAFMTG
 TRANSMEM /note="Helical" TRANSMEM /note="Helical" I->F:(4.0 %):LB/B -
323T---- 
VATILCFGMSEK
 TRANSMEM /note="Helical" TRANSMEM /note="Helical" T->A:(19.0 %):LB/B -
331M---- 
MLIFGVRSAC
 TRANSMEM /note="Helical" TRANSMEM /note="Helical" M->R:(6.0 %):LB/B -
334R---- 
RKS
 TOPO_DOM /note="Cytoplasmic" TOPO_DOM /note="Cytoplasmic" R->K:(17.0 %):LB/B -
335K---- 
KRMSWGNQAHV
 TOPO_DOM /note="Cytoplasmic" TOPO_DOM /note="Cytoplasmic" K->N:(5.0 %):LB/B -
338D---- 
GESDRAVP
 TOPO_DOM /note="Cytoplasmic" TOPO_DOM /note="Cytoplasmic" D->V:(4.0 %):LB/B -
345T---- 
TSVANQI
 COMPBIAS /note="Polar residues" REGION /note="Disordered" TOPO_DOM /note="Cytoplasmic" COMPBIAS /note="Polar residues" REGION /note="Disordered" DISORDER predicted by DISOPRED TOPO_DOM /note="Cytoplasmic" T->S:(25.0 %):LB/B -
358V---- 
VIMLED
 COMPBIAS /note="Polar residues" REGION /note="Disordered" TOPO_DOM /note="Cytoplasmic" COMPBIAS /note="Polar residues" REGION /note="Disordered" DISORDER predicted by DISOPRED TOPO_DOM /note="Cytoplasmic" V->M:(14.0 %):LB/B -